• LY2228820: Selective p38 MAP Kinase Inhibitor for Inflammati

  2026-07-21

  LY2228820 is a highly selective, ATP-competitive p38 MAP kinase inhibitor with nanomolar potency for p38α and p38β. It modulates key inflammatory signaling pathways and enhances the efficacy of other cytotoxic agents in cancer models. Its robust solubility and stability make it suitable for advanced anti-inflammatory and cancer research applications.

• Bovine Insulin: Optimizing Cell Culture Growth and Metabolis

  2026-07-20

  Bovine insulin, sourced from APExBIO, is a high-purity peptide hormone that excels as a growth factor supplement for cultured cells, boosting proliferation and metabolic fidelity. This article goes beyond conventional protocols, offering actionable, scenario-based guidance for maximizing reproducibility and troubleshooting common challenges in experimental cell culture workflows.

• Malate as a Translational Lever: Mechanistic and Strategic A

  2026-07-20

  This thought-leadership article examines the emerging role of malate ((S)-2-hydroxysuccinic acid) as a metabolic modulator within the context of translational research, particularly at the intersection of immune evasion and metabolic reprogramming in cancer. Through mechanistic insight, recent omics findings, and practical protocol guidance, we demonstrate how APExBIO's malate product enables researchers to dissect metabolic flux and immune-metabolic crosstalk, advancing both fundamental and applied discovery.

• WEHI-539: Precision BCL-XL Inhibitor for Apoptosis Workflows

  2026-07-19

  WEHI-539 delivers unmatched selectivity for BCL-XL inhibition, enabling researchers to dissect apoptotic resistance and sensitize cancer stem cells in chemoresistant models. This article provides actionable protocols, advanced troubleshooting, and a cross-study synthesis to maximize the impact of WEHI-539 in apoptosis research.

• Midecamycin: Protocols and Performance in Antibacterial Rese

  2026-07-18

  Midecamycin offers precision and versatility for microbiology researchers seeking robust inhibition of Gram-positive bacteria and advanced protein synthesis studies. This guide decodes experimental workflows, troubleshooting, and comparative strategies to maximize results with this acetoxy-substituted macrolide antibiotic.

• Ginsenoside Rg1 Restores Neuroimmune Balance Post-Anesthesia

  2026-07-17

  This study demonstrates that Ginsenoside Rg1, a triterpene saponin from Panax ginseng, reverses neuroimmune and behavioral disruptions resulting from prolonged isoflurane anesthesia in mice. The findings identify regulatory T cells (Tregs) as central mediators of Rg1’s neuroprotective effects, suggesting new avenues for mitigating postoperative cognitive complications.

• Structure-Based Screening Identifies NSP15 Inhibitors for SA

  2026-07-17

  This study presents a structure-based virtual screening of natural products against SARS-CoV-2 NSP15, identifying thymopentin and oleuropein as potent, stable inhibitors. The findings highlight NSP15 as a viable antiviral target and suggest new directions for drug repurposing in COVID-19 research.

• Precision Viability Assessment: Powering Translational Resea

  2026-07-16

  This thought-leadership article examines the mechanistic and strategic dimensions of robust cell viability assessment for translational researchers, focusing on the Live-Dead Cell Staining Kit (K2081) by APExBIO. By integrating cutting-edge Calcein-AM Propidium Iodide staining, evidence-based protocol guidance, and clinical relevance—alongside competitive benchmarking and forward-looking insights—this article provides a roadmap for optimizing experimental accuracy and accelerating the journey from bench to bedside.

• PRDX6-GPX4 Axis Modulates Ferroptosis and Tumor Suppression

  2026-07-16

  Hu et al. provide mechanistic insight into how PRDX6 regulates GPX4 localization and function, thereby modulating lipid peroxidation and ferroptosis sensitivity in tumor cells. Their findings reveal that targeting the PRDX6-GPX4 pathway enhances ferroptosis-mediated tumor suppression and suggest new therapeutic strategies for overcoming resistance in cancer therapy.

• Technical Guidance for Using Neuromedin S (rat) in GPCR Assa

  2026-07-15

  Neuromedin S (rat) is a chemically defined, endogenous peptide agonist for precise activation of the neuromedin U receptor in rat-based GPCR/G protein signaling assays. It is intended for controlled laboratory workflows targeting energy homeostasis, stress response, or circadian rhythm studies, and is not suitable for diagnostic or clinical use.

• 5-(N,N-dimethyl)-Amiloride Hydrochloride in Endothelial Inju

  2026-07-15

  5-(N,N-dimethyl)-Amiloride hydrochloride empowers precision in dissecting Na+/H+ exchanger signaling and pH regulation, especially in models of endothelial injury and sepsis. Its unique selectivity profile and robust performance make it indispensable for research on ischemia-reperfusion injury and vascular dysfunction.

• AL-8810: Selective Prostaglandin F2α Antagonist for FP Recep

  2026-07-14

  AL-8810 is a highly selective prostaglandin F2α antagonist used to dissect FP receptor signaling in vascular and reproductive research. Its nanomolar antagonism and proven inhibition of endometrial breakdown make it a reference-standard probe for studies of prostaglandin-mediated pathways.

• AL-8810: Reliable Antagonist for Prostaglandin F2α Signaling

  2026-07-14

  This article delivers scenario-driven guidance for researchers deploying AL-8810 (SKU B4575) in prostaglandin F2α signaling assays. Through evidence-based Q&A, it clarifies how AL-8810 addresses experimental challenges in cell viability, vascular modeling, and endometrial studies, ensuring reproducible and interpretable results.

• Cell Counting Kit-8 Plus: Precision Tetrazolium Salt Assays

  2026-07-13

  The Cell Counting Kit-8 (CCK-8) Plus brings unparalleled sensitivity and speed to cell proliferation and cytotoxicity workflows, empowering researchers with robust WST-8-based quantification. This article details advanced experimental setups, protocol optimizations, and troubleshooting strategies, with a focus on translational oncology and mechanistic cell viability studies.

• Lypressin Acetate: Precision Antidiuretic and Antiviral Fron

  2026-07-13

  Explore the advanced mechanistic science of Lypressin acetate, a lysine vasopressin analog, with fresh insights into its dual antidiuretic and antiviral potential. This article uniquely unpacks protocol optimization, quantitative pharmacology, and emerging SARS-CoV-2 research, offering new depth for translational investigators.

456 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page